Rheumatology News This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 8.

Extra Weight Linked to Rheumatoid Arthritis Risk in Women
November 10, 2012 (Newswise) — Being overweight is linked to a higher risk of rheumatoid arthritis in women, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Washington, D.C. read more
Source: Diabetes News from dLife.com - November 12, 2012 Category: Consumer Health News Authors: dlife Source Type: news

Novel Drug Builds Bone in Postmenopausal Osteoporotic WomenNovel Drug Builds Bone in Postmenopausal Osteoporotic Women
Odanacatib improved bone mineral density in postmenopausal women with persistent osteoporosis after 3 or more years of alendronate therapy. Medscape Medical News
Source: Medscape Today Headlines - November 12, 2012 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Rituxan Turns in Good Safety Profile in RA
WASHINGTON (MedPage Today) -- Serious infectious events associated with rituximab (Rituxan) remain consistently low in rheumatoid arthritis patients for nearly a decade after first treatment, researchers said here.
Source: MedPage Today Infectious Disease - November 12, 2012 Category: Infectious Diseases Source Type: news

New Phase 3 Findings Show STELARA® Significantly Reduced Signs And Symptoms Of Active Psoriatic Arthritis(Nov 12, 2012)
Washington, DC, November 12, 2012
Source: Johnson and Johnson - November 12, 2012 Category: Pharmaceuticals Source Type: news

Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression In Patients With Active Rheumatoid Arthritis(Nov 12, 2012)
Washington, DC, November 12, 2012 – New Phase 3 findings from a Janssen Research & Development, LLC (Janssen)-sponsored study showed treatment with the investigational intravenous (I.V.) therapy golimumab, a tumor necrosis factor (TNF) inhibitor, significantly inhibited radiographic progression in patients with active moderate to severe rheumatoid arthritis (RA) despite treatment with methotrexate. Analysis of study patients' X-rays showed significant inhibition of the progression of structural damage at week 24 in greater proportions of patients receiving I.V. golimumab plus methotrexate compared w...
Source: Johnson and Johnson - November 12, 2012 Category: Pharmaceuticals Source Type: news

Long-Term Efficacy and Safety Results of Epratuzumab in Lupus Presented at Rheumatology Conference
WASHINGTON, Nov. 12, 2012 (GLOBE NEWSWIRE) --
Source: Medical News (via PRIMEZONE) - November 12, 2012 Category: Pharmaceuticals Source Type: news

Abbott Announces Results of Analysis Exploring the Use of HUMIRA® (Adalimumab) in Simultaneously Achieving Three Key Treatment Goals for Rheumatoid Arthritis
Source: Abbott.com - November 12, 2012 Category: Pharmaceuticals Source Type: news

An Autoimmune Clotting Disorder Called Antiphospholipid Syndrome May Be Treatable With Statins
New research suggests that statins, traditionally used for cholesterol lowering, could be used in the management of individuals who are at risk for developing clotting because they have autoimmune antiphospholipid antibodies (aPL). The research will be presented in two presentations at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP). The meeting is being held Nov. 9-14, in Washington D.C...
Source: Health News from Medical News Today - November 12, 2012 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

Extra Pounds Linked to Rheumatoid Arthritis Risk in Women
Title: Extra Pounds Linked to Rheumatoid Arthritis Risk in WomenCategory: Health NewsCreated: 11/10/2012 6:35:00 PMLast Editorial Review: 11/12/2012 12:00:00 AM
Source: MedicineNet Arthritis General - November 12, 2012 Category: Rheumatology Source Type: news

Study: Rheumatoid Arthritis Plus Depression May Be Deadly
Title: Study: Rheumatoid Arthritis Plus Depression May Be DeadlyCategory: Health NewsCreated: 11/10/2012 6:35:00 PMLast Editorial Review: 11/12/2012 12:00:00 AM
Source: MedicineNet Arthritis General - November 12, 2012 Category: Rheumatology Source Type: news

Natural medicine therapies significantly benefit arthritis sufferers
A new study published in the November issue of the Journal of Clinical Nursing found that almost 25 percent of patients suffering from rheumatoid arthritis and osteoarthritis used a procedure known as complementary and alternative therapy (CAT) to help them better manage...
Source: NaturalNews.com - November 12, 2012 Category: Consumer Health Advice Source Type: news

Ontario Genomics Institute invests in stem cell technology at Tissue Regenerative Therapeutics
(Ontario Genomics Institute) The Ontario Genomics Institute, through its Pre-Commercialization Business Development Fund, has invested in Toronto-based Tissue Regenerative Therapeutics, a company that aims to use umbilical mesenchymal stem cells to treat a variety of serious medical conditions, such as arthritis, diabetes and Crohn's disease, to name a few.
Source: EurekAlert! - Medicine and Health - November 12, 2012 Category: Global & Universal Source Type: news

Investigational IV Golimumab Inhibits Structural Damage in RAInvestigational IV Golimumab Inhibits Structural Damage in RA
Intravenous golimumab slowed radiographic disease progression at week 24 and maintained the effect at week 52 in patients with rheumatoid arthritis. Medscape Medical News
Source: Medscape Today Headlines - November 11, 2012 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Decreasing medication does not equal more risks for people with rheumatoid arthritis in remission
Extending the time between doses, or tapering, TNF-inhibitor drugs in people with rheumatoid arthritis in remission can be done in some patients without significantly increasing disease activity or impairing joint function, according to new research findings.
Source: ScienceDaily Headlines - November 11, 2012 Category: Science Source Type: news

Researchers identify impact of rheumatoid arthritis and lupus on joint replacement surgery outcomes
Two new studies have overturned common beliefs about joint replacement in patients with lupus and rheumatoid arthritis.
Source: ScienceDaily Headlines - November 11, 2012 Category: Science Source Type: news

Expensive arthritis treatment no better than steroid therapy, study finds
A randomized, double-blind clinical trial has revealed that corticosteroids are more effective than the more expensive treatment in providing pain relief to patients with thumb arthritis.
Source: ScienceDaily Headlines - November 11, 2012 Category: Science Source Type: news

Depression risk factor for mortality in rheumatoid arthritis; men most at risk
Depression is higher in men and women with rheumatoid arthritis, and may increase mortality in this population, according to new research findings.
Source: ScienceDaily Headlines - November 11, 2012 Category: Science Source Type: news

Autoantibodies could be a warning sign for cardiovascular disease in people with rheumatoid arthritis
The presence of autoantibodies in the blood may be connected to a higher risk of the development of cardiovascular disease, not just in individuals with diagnosed autoimmune diseases like rheumatoid arthritis, but in the general population, according to new research findings.
Source: ScienceDaily Headlines - November 11, 2012 Category: Science Source Type: news

Extra weight linked to rheumatoid arthritis risk in women
Being overweight is linked to a higher risk of rheumatoid arthritis in women, according to new research findings.
Source: ScienceDaily Headlines - November 11, 2012 Category: Science Source Type: news

Biologics may prevent premature death in people with rheumatoid arthritis, study suggests
According to new research, treatment with biologic medications may reduce the risk of premature death in people with rheumatoid arthritis.
Source: ScienceDaily Headlines - November 11, 2012 Category: Science Source Type: news

Game changer for arthritis and anti-fibrosis drugs
Medical researchers have identified a way to treat inflammation while potentially minimizing a serious side effect of current medications: the increased risk for infection.
Source: ScienceDaily Headlines - November 11, 2012 Category: Science Source Type: news

Rheumatology Nursing Officially Recognized as a Nursing Specialty
Rheumatology Nursing officially recognized as a nursing specialty. Rheumatology Nurses Society (RNS) developed and submitted to the American Nursing Association a request for recognition of...(PRWeb November 10, 2012)Read the full story at http://www.prweb.com/releases/2012/11/prweb10119150.htm
Source: PRWeb: Medical Pharmaceuticals - November 11, 2012 Category: Pharmaceuticals Source Type: news

Ultrasound may help assess rheumatoid arthritis
Thanks to its ability to measure synovitis and detect joint damage, ultrasound (more)
Source: AuntMinnie.com Headlines - November 11, 2012 Category: Radiology Source Type: news

Game changer for arthritis and anti-fibrosis drugs
(University of Utah Health Sciences) In a discovery that can fundamentally change how drugs for arthritis, and potentially many other diseases, are made, University of Utah medical researchers have identified a way to treat inflammation without exposing patients to a serious side effect of current medications: the increased risk for infection.
Source: EurekAlert! - Medicine and Health - November 11, 2012 Category: Global & Universal Source Type: news

Crescendo Bioscience to Present Data on the Use of Vectra(TM) DA in Assessing Response to Treatments at American College of Rheumatology/Associate Rheumatology Health Professional Annual Meeting
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2012 (GLOBE NEWSWIRE) -- Crescendo Bioscience
Source: Medical News (via PRIMEZONE) - November 10, 2012 Category: Pharmaceuticals Source Type: news

Extra Pounds Linked to Rheumatoid Arthritis Risk in Women
Those who were overweight or obese were more likely to develop the painful disease, analysis showed Source: HealthDay Related MedlinePlus Pages: Body Weight, Rheumatoid Arthritis, Women's Health
Source: MedlinePlus Health News - November 10, 2012 Category: Consumer Health News Source Type: news

Ankylosing spondylitis and Klebsiella(Ebringer)
Source: Springer Medicine titles - November 10, 2012 Category: Databases & Libraries Tags: Rheumatology Source Type: news

Rheumatoid arthritis patients can get gout too, Mayo Clinic Study finds
(Mayo Clinic) Refuting a belief long held by many physicians, a Mayo Clinic study found that rheumatoid arthritis patients also can get gout. The research is among several studies Mayo Clinic is presenting at the American College of Rheumatology annual meeting in Washington.
Source: EurekAlert! - Medicine and Health - November 10, 2012 Category: Global & Universal Source Type: news

Researchers identify impact of rheumatoid arthritis and lupus on joint replacement surgery outcomes
(Hospital for Special Surgery) Two new studies by researchers at Hospital for Special Surgery have overturned common beliefs about joint replacement in patients with lupus and rheumatoid arthritis.
Source: EurekAlert! - Medicine and Health - November 10, 2012 Category: Global & Universal Source Type: news

Expensive arthritis treatment no better than steroid therapy
(Hospital for Special Surgery) A randomized, double-blind clinical trial by researchers at Hospital for Special Surgery has revealed that corticosteroids are more effective than the more expensive treatment, hylan G-F 20, in providing pain relief to patients with thumb arthritis.
Source: EurekAlert! - Medicine and Health - November 10, 2012 Category: Global & Universal Source Type: news

Copper insoles cured my arthritis, says the mother running a half marathon
Helen Basson, 39, from southern France, feared she would end up in a wheelchair after she was diagnosed with arthritis in every joint of her body.
Source: the Mail online | Health - November 9, 2012 Category: Consumer Health News Source Type: news

Back Pain Self-Management: Benefits Big Enough to Matter?Back Pain Self-Management: Benefits Big Enough to Matter?
Self-management of low back pain is widely recommended but produces small effects on pain and disability, according to a new meta-analysis. Medscape Medical News
Source: Medscape Today Headlines - November 8, 2012 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Medical Marijuana for Arthritis Pain
Arthritis is a medical condition, one that affections millions of people in America and commonly involves both pain and inflammation of a person’s joints as well as restricting their motion.
Source: Disabled World - November 8, 2012 Category: Disability Tags: Medical Marijuana Source Type: news

Vitamin D Tied to Arthritis Pain in Blacks (CME/CE)
(MedPage Today) -- The greater degree of pain reported by blacks with knee osteoarthritis may relate to their low levels of vitamin D, a cross-sectional study suggested.
Source: MedPage Today Geriatrics - November 8, 2012 Category: Geriatrics Source Type: news

New Oral Agent, Biologics to Star at ACR
WASHINGTON (MedPage Today) -- The annual meeting of the American College of Rheumatology is likely to see some excitement surrounding the FDA's approval this week of tofacitinib (Xeljanz).
Source: MedPage Today Primary Care - November 8, 2012 Category: Primary Care Source Type: news

Musculoskeletal Ultrasound: 14 Clinical Uses OutlinedMusculoskeletal Ultrasound: 14 Clinical Uses Outlined
The American College of Rheumatology Musculoskeletal Ultrasound Committee has recommended 14 reasonable uses for MSUS in clinical rheumatology practice. Medscape Medical News
Source: Medscape Today Headlines - November 8, 2012 Category: Consumer Health News Tags: Radiology News Source Type: news

Xeljanz Approved For Rheumatoid Arthritis Treatment By FDA
The U.S. Food and Drug Administration approved a drug by the name of Xeljanz (tofacitinib) for patients who have an insufficient or allergic response to methotrexate, as treatment for fiercely active rheumatoid arthritis. Rheumatoid arthritis (RA) is an autoimmune disease, in which the body's healthy tissue is under attack by the immune system. This leads to inflammation of the joints and surrounding tissues. RA affects about 1.5 million Americans according to the Centers for Disease Control and Prevention...
Source: Health News from Medical News Today - November 8, 2012 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Vitamin D Insufficiency Contributes To Pain In Black Americans With Knee Osteoarthritis
A new study reveals that black Americans display lower levels of vitamin D and greater pain sensitivity compared to white Americans. Findings published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), indicate that vitamin D deficiency may be one of many factors that account for increased pain in older black Americans with knee osteoarthritis (OA). Those with OA experience painful swelling and stiffness of the joints such as knees, hips and fingers...
Source: Health News from Medical News Today - November 8, 2012 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Renewal grant supports genetic research into arthritis of the spine
(University of Texas Health Science Center at Houston) An international team of scientists searching for genes that determine the susceptibility and severity of arthritis of the spine has been awarded a five-year renewal grant of $4.3 million from the National Institutes of Health.
Source: EurekAlert! - Medicine and Health - November 8, 2012 Category: Global & Universal Source Type: news

Osteoarthritis Knee Pain Linked to Vitamin D, RaceOsteoarthritis Knee Pain Linked to Vitamin D, Race
Lower vitamin D levels were more prominent in community-dwelling black patients than white patients in a cross-sectional study, and were also associated with diminished pain threshold. Medscape Medical News
Source: Medscape Today Headlines - November 7, 2012 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Obama Wins 4 More Years to Carry Out ACAObama Wins 4 More Years to Carry Out ACA
The president faces the challenge of implementing the Affordable Care Act in his second term, given staunch GOP opposition that is likely to continue. Medscape Medical News
Source: Medscape Rheumatology Headlines - November 7, 2012 Category: Rheumatology Tags: Family Medicine/Primary Care News Alert Source Type: news

F.D.A. Clears a Pfizer Treatment for Rheumatoid Arthritis
Regulators approved Pfizer’s Xeljanz treatment, which is now poised to compete with Abbott Laboratories’ top-selling Humira.
Source: NYT - November 7, 2012 Category: American Health Authors: By REUTERS Tags: Drugs (Pharmaceuticals) Rheumatoid Arthritis Abbott Laboratories ABT NYSE Pfizer Inc PFE NYSE Source Type: news

FDA approves Xeljanz for rheumatoid arthritis
Approved as a treatment for moderate to severe arthritis in patients who can't take, aren't helped by methotrexate
Source: Health News: CBSNews.com - November 7, 2012 Category: Consumer Health News Source Type: news

Pfizer arthritis drug wins approval, to challenge Humira
(Reuters) - U.S. regulators on Tuesday approved Pfizer Inc's Xeljanz treatment for rheumatoid arthritis, one of the company's most potentially lucrative experimental drugs, which is now poised to compete with Abbott Laboratories Inc's top-selling Humira.
Source: Reuters: Health - November 7, 2012 Category: Consumer Health News Tags: healthNews Source Type: news

New Arthritis Drug Xeljanz Gets FDA Approval
Title: New Arthritis Drug Xeljanz Gets FDA ApprovalCategory: Health NewsCreated: 11/7/2012 11:00:00 AMLast Editorial Review: 11/7/2012 12:00:00 AM
Source: MedicineNet Arthritis General - November 7, 2012 Category: Rheumatology Source Type: news

FDA Approves New Oral Therapy for Rheumatoid Arthritis
Source: Physician's First Watch current issue - November 7, 2012 Category: Primary Care Tags: Medical News Source Type: news

Horizon scanning: FDA approves tofacitinib (XeljanzT) for rheumatoid arthritis
Source: FDA Area: News The U.S. Food and Drug Administration has granted marketing authorisation for tofacitinib (XeljanzT) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to, or who are intolerant of, methotrexate. The approval is based on seven clinical trials which reported an improvement in clinical response and physical functioning in treated patients compared to patients treated with placebo. The use of tofacitinib was associated with an increased risk of serious infections, including opportunistic infections, tuberculosis, ...
Source: NeLM - News - November 7, 2012 Category: Drugs & Pharmacology Source Type: news

Lack of vitamin D contributes to pain in black Americans with knee osteoarthritis
(Wiley) A new study reveals that black Americans display lower levels of vitamin D and greater pain sensitivity compared to white Americans. Findings published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), indicate that vitamin D deficiency may be one of many factors that account for increased pain in older black Americans with knee osteoarthritis (OA).
Source: EurekAlert! - Medicine and Health - November 7, 2012 Category: Global & Universal Source Type: news

Ankylosing spondylitis and Klebsiella(Ebringer)
Source: Springer Medicine titles - November 6, 2012 Category: Databases & Libraries Tags: Rheumatology Source Type: news